Joseph Ronald Catapano - 01 Oct 2025 Form 4 Insider Report for Teladoc Health, Inc. (TDOC)

Role: Chief Accounting Officer
Signature: /s/ Adam C. Vandervoort, Attorney-in-Fact
Issuer symbol: TDOC
Transactions as of: 01 Oct 2025
Net transactions value: -$23,434
Form type: 4
Filing time: 03 Oct 2025, 16:05:34 UTC
Previous filing: 04 Mar 2025
Next filing: 06 Jan 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Catapano Joseph Ronald	Chief Accounting Officer	C/O TELADOC HEALTH, INC.,, 155 E 44TH ST, FLOOR 17, NEW YORK	/s/ Adam C. Vandervoort, Attorney-in-Fact	03 Oct 2025	0001714468

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TDOC	Common Stock	Options Exercise		+8,333			8,333	01 Oct 2025	Direct	F1
transaction	TDOC	Common Stock	Sale	$23,434	-2,972	-36%	$7.88	5,361	02 Oct 2025	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TDOC	Restricted Stock Units	Options Exercise	$0	-8,333	-33%	$0.000000	16,667	01 Oct 2025	Common Stock	8,333		Direct	F1, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
F2	Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards.
F3	On October 1, 2024, the reporting person was granted 25,000 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.